Trial Profile
Efficacy of mepolizumab in management of Drug Reaction with Eosinophilia and Systemic Symptoms (DRESS) syndrome relapses: a pilot study
Status:
Not yet recruiting
Phase of Trial:
Phase II
Latest Information Update: 05 Sep 2023
Price :
$35
*
At a glance
- Drugs Mepolizumab (Primary)
- Indications DRESS syndrome
- Focus Adverse reactions; Therapeutic Use
- 12 Oct 2021 New trial record